Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
electroCore, Inc. - Common Stock
(NQ:
ECOR
)
15.99
-0.27 (-1.66%)
Streaming Delayed Price
Updated: 11:15 AM EST, Dec 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about electroCore, Inc. - Common Stock
Ecora Resources PLC Announces Half year results
September 03, 2024
Via
ACCESSWIRE
iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023
September 25, 2023
Via
ACCESSWIRE
Electrocore Inc. (NASDAQ: ECOR) Near the Top of Equities by Percentage Gain on 3/24
March 24, 2023
Via
Investor Brand Network
electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
March 21, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Announces Reverse Stock Split
February 14, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
March 23, 2023
Pre-clinical trial demonstrates the ability of nVNS to decrease the amount of brain injury, decrease anxiety and improve motor function post injury
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
March 14, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
March 13, 2023
Poster Highlights the Ability of Non-Invasive Vagus Nerve Stimulation (nVNS) to Accelerate Learning of a Second Language
From
electroCore, Inc.
Via
GlobeNewswire
electroCore to Participate at 35th Annual Roth Conference
March 09, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Regains Compliance with Nasdaq Listing Requirements
March 07, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
March 01, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
February 16, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa
February 21, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Completes Sale of New Jersey Tax Benefits
February 15, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update
January 17, 2023
From
electroCore, Inc.
Via
GlobeNewswire
electroCore, Inc. Launches New Wellness Product Offering for Stress, Anxiety and Sleep, Truvaga™
December 20, 2022
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Announces Issuance of Two New U.S. Patents
December 07, 2022
From
electroCore, Inc.
Via
GlobeNewswire
gammaCore Sapphire™ Non-Invasive Vagus Nerve Stimulator (nVNS) Receives Unique National Product Code Number by the Belgian Pharmaceutical Association
November 18, 2022
From
electroCore, Inc.
Via
GlobeNewswire
electroCore to Participate at Canaccord Genuity MedTech and Diagnostics and Digital Health & Services Forum
November 14, 2022
From
electroCore, Inc.
Via
GlobeNewswire
electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC
November 01, 2022
From
electroCore, Inc.
Via
GlobeNewswire
electroCore to Announce Third Quarter 2022 Financial Results on November 3
October 27, 2022
From
electroCore, Inc.
Via
GlobeNewswire
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury
October 20, 2022
Pre-clinical trial demonstrates ability of nVNS to decrease amount of brain injury, decrease anxiety and improve motor function post injury
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Provides Select Third Quarter 2022 Financial Guidance
October 14, 2022
From
electroCore, Inc.
Via
GlobeNewswire
electroCore Inc. (NASDAQ: ECOR) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 10, 2022
Via
Investor Brand Network
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
October 04, 2021
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be...
From
MicroCap Rodeo
Via
AccessWire
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
May 27, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be...
From
MicroCap Rodeo
Via
AccessWire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.